揭示了基于网络药理学,acRIP-seq和实验验证的骨髓瘤 Remodelin 的药理学作用

Jia Gao1, Peili Xu1, Feng Wang2

  • 1Department of Orthopedics, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, 210011, Jiangsu, People's Republic of China.

Scientific reports
|February 12, 2024
PubMed
概括

雷莫德林通过向ESR2,IGF1和MAPK1.1,抑制骨髓瘤 (OS) 细胞的增殖. 这项研究阐明了Remodelin对OS的作用机制,确定了未来治疗策略的关键治疗点.